Dr. Constantinos Zamboglou
About Dr. Constantinos Zamboglou, PhD, MHBA is the Vice Medical Director of the German Medical Institute in Limassol and a Radiation Oncologist with international academic renown. He studied medicine at the Albert-Ludwigs-Universität Freiburg, Germany, where he completed his doctoral thesis summa cum laude and obtained his Habilitation (Postdoctoral Lecture Qualification) in 2020. He has been a Consultant and Clinician Scientist at the Medical Center University of Freiburg and led its Interventional Radiation Oncology section and Prostate Cancer Research Group. He has over 100 peer-reviewed publications, has received more than €8 million in research funding for clinical trials and health-technology innovation, and was awarded the prestigious Herman-Holthusen Award of the German Society of Radiation Oncology (DEGRO) in 2020. He is an invited member of the German expert panel for prostate cancer and the ESTRO focus group for genito-urethral cancer. His research focuses on PSMA-PET guided radiotherapy, prostate cancer, radiomic imaging, and AI-based contouring.
Contact with business owner
Your request has been submitted successfully.
Additional Information
Specializing
- Radiation Oncology
- Prostate Cancer Radiotherapy (PSMA-PET Guided)
- Genitourinary Cancer Radiotherapy
- Interventional Radiation Oncology
- SBRT & Focal Dose Escalation
- Brachytherapy (Salvage & Primary)
- Radiomic Imaging & AI-Based Tumour Segmentation
- PSMA-PET/CT in Prostate Cancer Staging
- Clinical Trials & Health Technology Implementation
Education
- MHBA — Friedrich Alexander University, Nuremberg, Germany (Sep 2021–Aug 2023)
- Habilitation (Postdoctoral Lecture Qualification) — University of Freiburg (Mar 2020)
- Board Certification in Radiotherapy & Radiation Oncology — Germany (Jan 2019)
- GCP & Clinical Trials Training — Clinical Trials Unit, University of Freiburg (May 2018)
- Doctoral Thesis (summa cum laude) — Institute of Pharmacology & Toxicology, University of Freiburg (Feb 2009–Feb 2012)
- Medical Degree — Albert-Ludwigs-Universität Freiburg, Germany (Oct 2008–May 2013)
- Medical Preliminary Examination (Physikum) — Semmelweis University, Budapest, Hungary (Sep 2006–Aug 2008)
Experience
- Vice Medical Director — German Medical Institute (GMI), Limassol, Cyprus (Jan 2022–Present)
- Prostate Cancer Research Group Leader — Medical Center University of Freiburg (Jan 2022–Present)
- Advanced Clinician Scientist — Bertha-Ottenstein Programme, University of Freiburg (Jan 2021–Dec 2022)
- Head of Interventional Radiation Oncology — Medical Center University of Freiburg (Jan–Dec 2021)
- Consultant — Department of Radiation Oncology, Medical Center University of Freiburg (Jun 2019–Present)
- Clinician Scientist — Bertha-Ottenstein Programme, University of Freiburg (Jul 2017–Jul 2020)
- Residency — Department of Radiation Oncology, Medical Center University of Freiburg (Sep 2013–Jan 2019)
Awards & Distinctions
- Annual ARO Study Prize — HypoFocal-SBRT Study, German Cancer Foundation (2023)
- Invited Member, ESTRO Focus Group “Urology” (2023)
- Best Abstract — EMUC Congress, Athens (2021)
- Invited Member, ESTRO-ACROP Guideline Committee for Prostate Cancer (2021)
- Herman-Holthusen Award — German Society of Radiation Oncology (DEGRO) (2020)
- Invited Member, German Expert Panel for Prostate Cancer, DEGRO (2020)
- Poster Prize — Uro-Oncological Symposium, Magdeburg (2019)
- Poster Prize — DEGRO Annual Meeting, Berlin (2017)
- Sanofi-Aventis Poster Prize — German Society of Pharmacology and Toxicology (2010)
Publications (selected — 100+ total)
- Zamboglou C. et al. — Multi-institutional Nomogram for PSMA-PET-Based Salvage Radiotherapy in Recurrent Prostate Cancer. JAMA Network Open (2023)
- Zamboglou C. et al. — Metastasis-Free Survival after PSMA-PET-Guided Salvage Radiotherapy. Int J Radiation Oncology (2022)
- Zamboglou C. et al. — PSMA-PET & MRI-Based Focal Dose Escalation in Primary Prostate Cancer (ARO2020-01 Phase 2). Int J Radiation Oncology (2022)
- Spohn S., Zamboglou C. et al. — Radiomics in Prostate Cancer: Systematic Review on Validated Studies. Theranostics (2021)
- Kostyszyn D., Zamboglou C. et al. — Intraprostatic Tumour Segmentation on PSMA-PET with Convolutional Neural Network. J Nucl Med (2020)
- Zamboglou C. et al. — Validation of PSMA-PET/CT-based Contouring vs Histopathology. Radiother Oncol (2019)
- Zamboglou C. et al. — Radiomic Features from PSMA PET for Intraprostatic Tumour Characterisation. Theranostics (2019)
- Zamboglou C. et al. — Comparison of 68Ga-HBED-CC PSMA-PET/CT and mpMRI for Gross Tumour Volume Detection. Theranostics (2017)
- Zamboglou C. et al. — 68Ga-HBED-CC-PSMA PET/CT vs Histopathology: Voxel-Wise Comparison. Theranostics (2016)
Memberships
- ESTRO (European Society for Radiotherapy and Oncology) — Focus Group Urology
- DEGRO (German Society of Radiation Oncology) — German Prostate Cancer Expert Panel
- ESTRO-ACROP Guideline Committee for Prostate Cancer
Contact Information
GHS Doctors
Language
Σήμερα
24 hours open
Monday
24 hours open
Tuesday
24 hours open
Wednesday
24 hours open
Thursday
24 hours open
Friday
24 hours open
Saturday
24 hours open
Sunday
24 hours open
Εμπειρίες ασθενών
Συνολική βαθμολογία
Βαθμολογήστε την εμπειρία σας
Πόσο πιθανό είναι να μας συστήσετε
Βαθμολογήστε μας και γράψτε μια κριτική
